semaglutide after sleeve gastrectomy weight regain study maintenance discontinuation of GLP-1 therapies Weight Regain after Stopping Obesity

Xiaogang Qin, [email protected] These authors have contributed equally to this work This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

USA Sino Biological Inc Cube Biotech Abcam plc GoldBio GenScript Cepham Life Sciences

PMID: 4388022

Source: pubmed.ncbi.nlm.nih.gov/40675372/ New research highlights the use of #GLP1 receptor agonists (like semaglutide & tirzepatide) in treating mast cell activation syndrome (MCAS)

Personalization also means having the support to adjust